Asthavent
4-[2-(tert-Butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)phenol
Drag to rotate; arrow keys step through the atoms. Structure from PubChem CID 2083.
Registration
- Applicants
- 1
- Registrations
- 2
Applicants and registrations
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Asthavent EACH ACTUATION CONTAINS SALBUTAMOL 100 mcg | Not listed | 30011930/10.2.1/0119 | Cancelled | Not determined | None |
| Asthavent syrup EACH 5 ml SYRUP CONTAINS SALBUTAMOL SULPHATE EQUIVALENT TO 2 mg SALBUTAMOL | 2,0 mg/5 mLSyrup | 30020030/10.2.2/0200Approved 8 March 2023 | Registered | Not determined | PIPIL |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
Listings for this ingredient that could not be applied to this product
S4: Salbutamol
- when intended for injection.
Consolidated Schedules 06 July 2026, line 7867
S3: Ipratropium
- when contained in respirator solutions.
Consolidated Schedules 06 July 2026, line 3804
S3: Salbutamol
- when contained in respirator solutions.
Consolidated Schedules 06 July 2026, line 4238
S2: Ipratropium
- except when contained in respirator solutions.
Consolidated Schedules 06 July 2026, line 2177
S2: Salbutamol
- when contained in respirator solutions; (S3) and
- when intended for injection. (S4)
Consolidated Schedules 06 July 2026, lines 2654 to 2658
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
Background
SAHPRA documents
These documents come from SAHPRA's PI-PIL repository unless the line under a document says otherwise. Always consult with a healthcare professional for medical advice.